Paper15465337
Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides.
Chen HS and 6 others. Bioorg Med Chem, 2004. Cited by 116 papers, by iCite.
Cite this record
ConductScience Library. Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Papers, record 15465337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15465337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Cytokines | Major topic |
| Immunologic Factors | Major topic |
| Polysaccharides | Major topic |
| Reishi | Major topic |
| Animals | |
| Dose-Response Relationship, Drug | |
| Granulocyte Colony-Stimulating Factor | |
| Interleukin-1 | |
| Interleukin-12 | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Spleen | |
| Tumor Necrosis Factor-alpha |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42762394 | Unraveling the cytoprotective mechanism of polysaccharides in heat-stressed rabbits: antioxidant, anti-inflammatory, physiological status, and molecular docking assessment. | Vet Res Commun | 2026 | https://conductscience.org/library/papers/42762394 | PubMed |
| 41328236 | The protective effects of Ganoderma lucidum polysaccharides on blood physiology, immune function, and organ architecture in growing stressed rabbits. | J Adv Vet Anim Res | 2025 | https://conductscience.org/library/papers/41328236 | PubMed |
| 40661810 | A Review of Bioactive Components and Pharmacological Effects of Ganoderma lucidum. | Food Sci Nutr | 2025 | https://conductscience.org/library/papers/40661810 | PubMed |
| 38398467 | Exploring the Therapeutic Potential of Ganoderma lucidum in Cancer. | J Clin Med | 2024 | https://conductscience.org/library/papers/38398467 | PubMed |
| 38001761 | Natural Bio-Compounds from Ganoderma lucidum and Their Beneficial Biological Actions for Anticancer Application: A Review. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38001761 | PubMed |
| 37833299 | Ganoderma lucidum methanolic extract as a potent phytoconstituent: characterization, in-vitro antimicrobial and cytotoxic activity. | Sci Rep | 2023 | https://conductscience.org/library/papers/37833299 | PubMed |
| 37175546 | The Role of NQO1 in Ovarian Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37175546 | PubMed |
| 36676192 | Exploring the Bioactive Mycocompounds (Fungal Compounds) of Selected Medicinal Mushrooms and Their Potentials against HPV Infection and Associated Cancer in Humans. | Life (Basel) | 2023 | https://conductscience.org/library/papers/36676192 | PubMed |
| 35935849 | Antioxidant, antibacterial, antitumor, antifungal, antiviral, anti-inflammatory, and nevro-protective activity of Ganoderma lucidum: An overview. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35935849 | PubMed |
| 35890166 | How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology? | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35890166 | PubMed |
| 35859110 | Immunomodulatory activity of extracts from five edible basidiomycetes mushrooms in Wistar albino rats. | Sci Rep | 2022 | https://conductscience.org/library/papers/35859110 | PubMed |
| 34960904 | WSG, a Glucose-Rich Polysaccharide from Ganoderma lucidum, Combined with Cisplatin Potentiates Inhibition of Lung Cancer In Vitro and In Vivo. | Polymers (Basel) | 2021 | https://conductscience.org/library/papers/34960904 | PubMed |
| 34855004 | Anti-tumor effect of polysaccharide from Pleurotus ostreatus on H22 mouse Hepatoma ascites in-vivo and hepatocellular carcinoma in-vitro model. | AMB Express | 2021 | https://conductscience.org/library/papers/34855004 | PubMed |
| 33613827 | Characterization and Hepatoprotections of Ganoderma lucidum Polysaccharides against Multiple Organ Dysfunction Syndrome in Mice. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/33613827 | PubMed |
| 31915457 | A Comparison of Characterization and Its Actions on Immunocompetent Cells of Polysaccharides from Sijunzi Decoction. | Evid Based Complement Alternat Med | 2019 | https://conductscience.org/library/papers/31915457 | PubMed |
| 31442262 | GSP-2, a polysaccharide extracted from Ganoderma sinense, is a novel toll-like receptor 4 agonist. | PLoS One | 2019 | https://conductscience.org/library/papers/31442262 | PubMed |
| 30899156 | Isolation and characterization of Aspergillus sp. for the production of extracellular polysaccharides by response surface methodology. | Saudi J Biol Sci | 2019 | https://conductscience.org/library/papers/30899156 | PubMed |
| 30410443 | Ganoderma: A Cancer Immunotherapy Review. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30410443 | PubMed |
| 29861482 | A Modified GC-MS Analytical Procedure for Separation and Detection of Multiple Classes of Carbohydrates. | Molecules | 2018 | https://conductscience.org/library/papers/29861482 | PubMed |
| 29849725 | Potential of Mushroom Compounds as Immunomodulators in Cancer Immunotherapy: A Review. | Evid Based Complement Alternat Med | 2018 | https://conductscience.org/library/papers/29849725 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15465337
GET https://conductscience.org/api/papers/v1/15465337/cited_by?page=2